Physician profile
David Mullins
NPI 1427368943
$2,367.59
in general payments reported to CMS, 2019-2025
30 companies · $848 in 2025
The $848 reported for 2025 was more than what 83% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $464 · 2022: $142 · 2023: $273 · 2024: $640 · 2025: $848.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,691 · Education: $69.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,691.46 |
| Education | $69.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $241.79 | 2021-2023 | Xarelto |
| Novartis Pharmaceuticals Corporation | $228.09 | 2024-2025 | |
| Abbott Laboratories | $198.87 | 2021-2025 | Amplatzer Amulet |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $189.75 | 2021-2025 | Lifevest |
| Astrazeneca Pharmaceuticals LP | $177.52 | 2021-2025 | Wainua, Farxiga |
| Atricure, INC. | $135.08 | 2023-2025 | Synergy Ablation System, Atriclip Laa Exclusion System |
| Actelion Pharmaceuticals US, INC. | $116.45 | 2024-2025 | Uptravi, Opsumit |
| E.R. Squibb & Sons, L.L.C. | $111.28 | 2021-2025 | Camzyos, Eliquis |
| Kestra Medical Technology Services, INC. | $103.77 | 2025 | Assure Wcd |
| Boston Scientific Corporation | $96.03 | 2023-2025 | Bodyguardian, Watchman Flx, Watchman Access System |
| Boehringer Ingelheim Pharmaceuticals, INC. | $92.11 | 2021-2025 | Jardiance |
| Scpharmaceuticals INC. | $82.09 | 2024-2025 | |
| Edwards Lifesciences Corporation | $80.04 | 2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Alnylam Pharmaceuticals INC. | $78.23 | 2022-2025 | Amvuttra |
| Pfizer INC. | $59.51 | 2021-2023 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lantheus Medical Imaging, INC. | $53.49 | 2024 | |
| Vital Connect, INC | $39.69 | 2024-2025 | Vitalpatch Rtm |
| Bayer Healthcare Pharmaceuticals INC. | $33.01 | 2024-2025 | |
| Xeris Pharmaceuticals, INC. | $30.59 | 2021 | |
| Amgen INC. | $30.30 | 2024 | Repatha |
| Inspire Medical Systems, INC. | $27.14 | 2025 | Inspire |
| Lexicon Pharmaceuticals, INC. | $22.43 | 2023 | Inpefa |
| Bridgebio Pharma, INC. | $20.78 | 2025 | Attruby |
| Kiniksa Pharmaceuticals International, Plc | $20.71 | 2024 | Arcalyst |
| Heartflow, INC. | $20.69 | 2025 | |
| Novo Nordisk INC | $17.61 | 2025 | Ozempic |
| Esperion Therapeutics, INC. | $15.97 | 2021 | |
| Abbvie INC. | $15.72 | 2023 | |
| Sanofi-Aventis U.S. LLC | $14.75 | 2023 | |
| Philips North America LLC | $14.10 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Mullins listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.